Licensing and Access to Medicines and Vaccines - 22 November 2023 скачать в хорошем качестве

Licensing and Access to Medicines and Vaccines - 22 November 2023

Public support, through funding and other form of assistance, is critical for biomedical research & development (R&D) and instrumental in allowing innovative health technologies reaching markets and patients. On many occasions such support, economic or in-kind, is decisive in the early stages of R&D of products that are then marketed by companies for extortionate prices, generating huge profits. However, it is difficult to ensure a minimum of public return on that investment. Salud por Derecho and Health Action International jointly convened a round-table discussion titled “Licensing and access to medicines and vaccines: obstacles and proposals for improving access”. The event addressed the following: • Ongoing discussions at EU (pharma strategy) and Global (INB) levels regarding access to results from publicly supported R&D • Trends in dissemination of publicly generated knowledge: licensing strategies, access clauses and societal impact. • Identify opportunities and obstacles for effective tech transfer from public research institutions • Gather the inputs of advocates, practitioners and experts on technology transfer, public return and benefit sharing.